Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"Nice Insight’s thought-provoking data gave me new insight into existing
companies that outsource research and manufacturing services and products."
Director of Chemical Product R&D, Specialty Pharmaceutical Company, North America  
BioProcess International Conference
September 16-20 Boston, MA |
Cirrus Pharmaceuticals Galenix Inc. GlaxoSmithKline Biopharmaceuticals Oso BioPharmaceuticals Manufacturing, LLC Patheon Inc. Pfizer CentreSource Boehringer Ingelheim GmbH Pharma Tech Industries Pillar5 Pharma, Inc Recipharm AB
Takeda Pharmaceuticals International GmbH, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, is a global pharmaceutical company with a diversified portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. The company also offers a range of OTC products and its many products are sold in more than 100 countries. The company’s R&D is structured around collaborations.
http://
Regions
Stock Symbol Private Filter of 's services per Nice Insight Categories
Contact 
|
|
|
